Molecular Partners Aktie

4,90CHF -0,25CHF -4,85%
Molecular Partners für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A12DEH / ISIN: CH0256379097
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 89,49
BVF Partners LP 10,93
Suvretta Capital Management LLC 10,62
Novartis AG 4,31
EcoR1 Capital, LLC 2,69
Hansjörg Wyss 2,67
GAM Investment Management (Switzerland) AG 2,65
Michael Tobias Stumpp, PhD 1,90
GAM Swiss Sustainable Companies 1,26
UBAM - Swiss Equity 0,89
GAM Multistock - Swiss Small & Mid Cap Equity 0,73
UBS (CH) Equity Fund - Switzerland Sustainable (CHF) 0,69
UBS (CH) Equity Fund - Small Caps Switzerland (CHF) 0,59
Andreas Emmenegger, EMBA 0,59

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 147 159 177 191 182
Umsatz pro Mitarbeiter in Mio. EUR 0,14 0,06 0,06 0,99 0,04

Bilanz (in Mio. CHF) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 100 178 164 255 192
Summe Anlagevermögen 5 10 8 8 6
Summe Aktiva 105 188 173 262 198

Bilanz (in Mio. CHF) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 3 7 6 5 4
Summe Fremdkapital 51 80 65 27 22
Summe Eigenkapital 54 107 107 235 176
Summe Passiva 105 188 173 262 198

Adresse

Wagistrasse 14, 8952 Schlieren
Telefon +41 (44) 755-77-00
Fax +41 (44) 755-77-07
Internet http://www.molecularpartners.com

Management

Agnete Brunsvik Fredriksen
Independent Director
Alexander Zürcher
Chief Operating Officer
Anne Goubier
Senior VP-Research & Early Development
Baris Arican
Vice President-Information Technology
Daniel Steiner
Senior Vice President-Research & Technology
Dominik Höchli
Independent Director
Michael J. Vasconcelles
Independent Non-Executive Director
Michael Pitzner
SVP-Legal, General Counsel & Compliance Officer
Michael Tobias Stumpp
Executive Vice President-Projects
Patrick Amstutz
Chief Executive Officer & Director
Philippe Legenne
Chief Medical Officer
Renate Gloggner
Executive VP-People, Community & Culture
Robert Hendriks
Senior Vice President-Finance
Sandipkumar S. Kapadia
Independent Director
Seth D. Lewis
SVP-Investor Relations, Communications & Strategy
Steven H. Holtzman
Independent Non-Executive Director
Vito J Palombella
Independent Director
William Matt Burns
Chairman